Late onset of de novo atypical hemolytic–uremic syndrome presented on a simultaneous pancreas and kidney transplant recipient successfully treated with eculizumab Francisco Javier Juega-Mariño, Neus Sala, Dolores López, Laura Cañas, Josep Bonet, Ricardo Lauzurica

Eculizumab as a treatment for atypical hemolytic uremic syndrome secondary to carfilzomib Candela Moliz, Eduardo Gutiérrez, Teresa Cavero, Beatriz Redondo, Manuel Praga

Hepatotoxicity associated with eculizumab in a patient with atypical hemolytic uremic syndrome Aysegul Oruc, Yavuz Ayar, Berna Aytac Vuruskan, Abdulmecit Yildiz, Nimet Aktas, Mahmut Yavuz, Mustafa Gullulu, Kamil Dilek, Alparslan Ersoy